IP Library Granted Patent US 8,492,364
Granted Patent B2
US 8,492,364 · App. 13/055,178 · Granted Jul 23, 2013

Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides

Inventors: Gerald B. Pier (Brookline, MA); Nikolay Nifantiev (Moscow, RU); Yury Tsvetkov (Moscow, RU); Marina Gening (Moscow, RU)
Assignee: The Brigham and Women's Hospital, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,492,364
App. No.
13/055,178
Granted
Jul 23, 2013
Kind
B2
Abstract

The invention relates to the compositions of synthetic oligo-β-(1→6)-2-amino-2-deoxy-D-glucopyranosides conjugated to carriers, and methods for making and use same.

Claims (13)

1. A composition comprising

an oligosaccharide-carrier conjugate comprising an oligosaccharide conjugated to a carrier through a linker that is

wherein n is greater than l, m is a number selected from 1 to 10, p is a number selected from 1 to 20, and R is H or an alkyl group, and

wherein the linker is O-linked to the oligosaccharide and N-linked to the carrier, the oligosaccharide is a β-1,6-linked glucosamine and the carrier is a peptide or protein.

2. The composition of claim 1 , wherein the carrier is tetanus toxoid.

3. The composition of claim 1 , wherein the composition has an oligosaccharide to carrier ratio of 1:1, 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1, 10:1, 20:1, 30:1, 40:1, 50:1, 60:1, 70:1, 80:1, 90:1 or 100:1.

4. The composition of claim 1 , wherein the oligosaccharide is 2-20 monomers in length.

5. The composition of claim 1 , wherein the oligosaccharide is 5-11 monomers in length.

6. The composition of claim 1 , wherein the oligosaccharide is 7, 9 or 11 monomers in length.

7. The composition of claim 1 , wherein the oligosaccharide is 0-40% acetylated.

8. The composition of claim 1 , further comprising a pharmaceutically acceptable carrier.

9. The composition of claim 1 , further comprising an adjuvant.

10. The composition of claim 1 , further comprising an anti-bacterial agent.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 31, 2015
From: BRIGHAM AND WOMEN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036514/0798 →
CONFIRMATORY LICENSE Recorded Jul 23, 2013
From: BRIGHAM & WOMEN'S HOSPITAL, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030873/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2011
From: NIFANTIEV, NIKOLAY; TSVETKOV, YURY; PIER, GERALD B; GENING, MARINA
To: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 025825/0845 →
Continuity (3)
Provisional Application 61135493 · Jul 21, 2008
Provisional Application 61208155 · Feb 20, 2009
Related Publication 20110150880A1 · Jun 23, 2011